Northern Trust’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
75,782
+714
| +1% | +$2.45K | ﹤0.01% | 3849 |
|
|
2025
Q1 | $167K | Sell |
75,068
-6,553
| -8% | -$14.6K | ﹤0.01% | 3991 |
|
|
2024
Q4 | $239K | Buy |
81,621
+42,174
| +107% | +$124K | ﹤0.01% | 3923 |
|
|
2024
Q3 | $103K | Sell |
39,447
-935
| -2% | -$2.43K | ﹤0.01% | 4049 |
|
|
2024
Q2 | $120K | Sell |
40,382
-7,309
| -15% | -$21.6K | ﹤0.01% | 4010 |
|
|
2024
Q1 | $216K | Sell |
47,691
-8,786
| -16% | -$39.8K | ﹤0.01% | 3867 |
|
|
2023
Q4 | $322K | Buy |
+56,477
| New | +$322K | ﹤0.01% | 3703 |
|
|
2023
Q3 | – | Sell |
-100,268
| Closed | -$648K | – | 4461 |
|
|
2023
Q2 | $648K | Sell |
100,268
-1,585,189
| -94% | -$10.2M | ﹤0.01% | 3481 |
|
|
2023
Q1 | $12.7M | Sell |
1,685,457
-55,960
| -3% | -$422K | ﹤0.01% | 1863 |
|
|
2022
Q4 | $17.6M | Buy |
1,741,417
+234,169
| +16% | +$2.37M | ﹤0.01% | 1619 |
|
|
2022
Q3 | $14.9M | Buy |
1,507,248
+87,819
| +6% | +$869K | ﹤0.01% | 1696 |
|
|
2022
Q2 | $15.1M | Buy |
+1,419,429
| New | +$15.1M | ﹤0.01% | 1729 |
|